Get the SPI Wire

CO-DIAGNOSTICS, INC.

NASDAQ:CODX
Annual Meeting

of Shareholders

MEETING DATE

11/13/2026
DEF 14A FILED
10/26/2026
PUBLISHED
10/26/2026 8:00 pm
TIME TO PUBLISH
10/28/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:CODX · CUSIP 189763105 · CLASS common stock, $0.001 par value per share · CIK 0001692415

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

8
FOR
1
AGAINST
0
WITHHOLD
9
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of five (5) directors to our Board of Directors
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated five directors and states no nominee is unable or unwilling to serve.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Approval of an increase in the number of shares authorized for issuance under the Co-Diagnostics, Inc. 2025 Equity Incentive Plan
compensation
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states 163,376 shares remained available for future awards under the plan.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Advisory vote on executive compensation
compensation
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states the compensation committee will consider the outcome when making future compensation decisions.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
Ratification of Tanner LLC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026
auditor
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states all fees incurred were pre-approved by the audit committee.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
Amendment to the Company's Articles of Incorporation to set the quorum requirement for stockholder meetings at one-third (1/3)
other
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states the amendment does not alter the vote required to approve any particular matter.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
6
Approval of the potential exercise of the new warrants to purchase an aggregate of 3,404,724 shares of common stock
other
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Approval is a condition for potential gross proceeds of approximately $5.31 million upon cash exercise.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
7
Approval, for purposes of Nasdaq Listing Rule 5635(d), of the issuance of shares of common stock issuable upon conversion of the secured convertible notes
other
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states stockholder approval is required under Nasdaq Listing Rule 5635 for the note conversion shares.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
8
Approval of an amendment to the Company's Articles of Incorporation to effect one or more reverse stock splits
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states the reverse split could have an anti-takeover effect and increase management flexibility to resist favored takeover bids.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
9
Approval of the adjournment proposal
other
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states adjournment would provide additional time to solicit proxies for Proposals 1 to 8.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

1d1e5000d7eef51adab9f7acbf709f98f2d582e11cd8ba35ecebac5c6d118998

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates